https://orcid.org/0000-0001-6767-0293
Citations (48)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Ruyun Gao, Cuiling Zheng, Mengwei Yang, Liyuan Dai, Chen Chen, Jiarui Yao, Zhishang Zhang, Le Tang, Yuankai Shi & Xiaohong Han. (2023) Immunogenicity assessment of elder hepatocellular carcinoma patients after inactivated whole-virion SARS-CoV-2 vaccination. Expert Review of Vaccines 22:1, pages 1102-1113.
Read now
Read now
Çağlar Ünal, Gülşah Tunçer, Betül Çopur, Kezban Nur Pilanci, Kerem Sadi Okutur, Kanay Yararbaş, Özkan Alan, Abdullah Sakin, Melih Simsek, İpek Özönder Ünal, Atakan Topçu, Zeynep Alaca Topçu, Tomris Duymaz & Çetin Ordu. (2023) Clinical and inflammation marker features of cancer patients with COVID-19: data of Istanbul, Turkey multicenter cancer patients (2020–2022). Current Medical Research and Opinion 39:7, pages 987-996.
Read now
Read now
Paathum Sookaromdee & Viroj Wiwanitkit. (2023) Perceptions of COVID-19 Vaccination in Patients with Genitourinary Cancers: Correspondence. Cancer Investigation 41:1, pages 107-108.
Read now
Read now
Juntao Yin, Yangyang Chen, Yang Li, Xingwang Zhang & Chaoyang Wang. (2022) Seroconversion rate after COVID-19 vaccination in patients with solid cancer: A systematic review and meta-analysis. Human Vaccines & Immunotherapeutics 18:6.
Read now
Read now
Mateus Nóbrega Aoki, Jeanine Marie Nardin, Luciano Fernandes Huergo, Lucas Blanes, Hugo Manuel Paz Morales, Bruna Fornazari, Marcelo Santos Conzentino, Maria Eduarda Alencar Migliorini & Dalila Lucíola Zanette. (2022) Dynamics of the Immune Response in Hospitalized SARS-CoV-2-infected Cancer Patients. Cancer Investigation 40:9, pages 750-759.
Read now
Read now
Danial Fazilat-Panah, Hamid Fallah Tafti, Yavar Rajabzadeh, Maedeh Alsadat Fatemi, Nahid Ahmadi, Davoud Jahansouz, Mohsen Tabasi, Seyed Alireza Javadinia, Maryam Joudi, Hadi Harati, Fahimeh Attarian & Farzad Taghizadeh-Hesary. (2022) Clinical Characteristics and Outcomes of COVID-19 in 1294 New Cancer Patients: Single-Center, Prospective Cohort Study from Iran. Cancer Investigation 40:6, pages 505-515.
Read now
Read now
Seyed Alireza Javadinia, Mona Ariamanesh, Maryam Nabavifard, Pejman Porouhan, Babak PeyroShabany, Danial Fazilat-Panah, Farbod Hatami, Ahmad Ghasemi, Gary H. Lyman, James S. Welsh, Somayeh Ashkar Tizabi & Mansoureh Dehghani. (2022) Multicenter Study of Antibody Seroprevalence against COVID-19 in Patients Presenting to Iranian Cancer Centers after One Year of the COVID-19 Pandemic. Cancer Investigation 40:2, pages 115-123.
Read now
Read now
Articles from other publishers (41)
P. Pedrazzoli, A. Lasagna, I. Cassaniti, A. Piralla, A. Squeri, R. Bruno, P. Sacchi, F. Baldanti, M. Di Maio, G.D. Beretta, S. Cinieri & N. Silvestris. (2023) Vaccination for seasonal influenza, pneumococcal infection and SARS-CoV-2 in patients with solid tumors: recommendations of the Associazione Italiana di Oncologia Medica (AIOM). ESMO Open 8:3, pages 101215.
Crossref
Crossref
Mario Caccese, Anna Maria Saieva, Valentina Guarneri, Sara Lonardi, Massimo Cacco, Vanna Chiarion Sileni, Michele Gottardi, Eleonora Mioranza, Francesca Bergamo, Antonella Brunello, Vittorina Zagonel & Patrizia Benini. (2022)
Antigen rapid diagnostic test monitoring for
SARS‐CoV
‐2 in asymptomatic and fully vaccinated cancer patients: Is it cost‐effective?
. Cancer Medicine 12:7, pages 7795-7800.
Crossref
Crossref
Pengru Wang, Bo Li, Shangbin Zhou, Yingye Xin, Zhipeng Zhu, Shujie Duan, Danyang Bai, Hao Yuan, Wei Xu & Jianru Xiao. (2023) Efficacy and safety of COVID-19 vaccines for patients with spinal tumors receiving denosumab treatment: An initial real−clinical experience study. Frontiers in Oncology 13.
Crossref
Crossref
Durgesh Wankhede, Sandeep Grover & Paul Hofman. (2023) Determinants of humoral immune response to SARS-CoV-2 vaccines in solid cancer patients: A systematic review and meta-analysis. Vaccine 41:11, pages 1791-1798.
Crossref
Crossref
Negar Deldadeh, Shahpar Haghighat, Zahra Omidi, Ramin Sarrami-Foroushani, Alireza Madjid Ansari, Hassan Sanati, Azadeh Azizi, Farid Zayeri, Flora Forouzesh, Teunis B.H. Geijtenbeek & Mohammad Amin Javidi. (2023) Anti-cancer effect of COVID-19 vaccines in 4T1 mice models. Life Sciences, pages 121569.
Crossref
Crossref
Kyoungmin Lee, In Hae Park, Sang Cheul Oh, Jae Hong Seo, Min Ji Jeon, Eun Sang Yu, Dae Sik Kim, Chul Won Choi, Ah‐reum Lim, Myung Han Hyun, Ju Won Kim, Jwa Hoon Kim, Yoon Ji Choi, Soohyeon Lee, Kyong Hwa Park, Yeul Hong Kim, Jung Yoon Choi, Jung Sun Kim, Se Ryeon Lee, Hwa Jung Sung & Eun Joo Kang. (2022) Perception and safety analysis of COVID‐19 vaccination in cancer patients: A multicenter, real‐world study. Cancer Medicine 12:5, pages 5558-5568.
Crossref
Crossref
Shanshan Han, Yuping Yang, Tingrui Wang, Rui Song, Daixing Hu, Mingli Peng, Zijing Lin, Qin Deng, Hong Ren & Jia Ming. (2023) Safety and immunogenicity of the third (booster) dose of inactivated and recombinant protein SARS-CoV-2 vaccine for patients with endocrine-related cancer. Frontiers in Public Health 11.
Crossref
Crossref
Dong Chen, Yuancan Pan, Yue Wang, Xing Chen, Jiahui Zhang, Yutong Zhang, Tongjing Ding, Zhengzheng Yang, Taicheng Lu, Yingying Zheng, Jiangyan Wei, Weijia Kong, Haiming Li, Xiaohui Yin, Guowang Yang, Ganlin Zhang & Xiaomin Wang. (2023) Serological response to COVID-19 vaccine and its predictors in patients with solid malignancies: A systematic review and meta-analysis of 16 cohort studies. Journal of Infection 86:2, pages 154-225.
Crossref
Crossref
Yash B. Shah, Stephanie Kjelstrom, Diana Martinez, Adam Leitenberger, Donna‐Marie Manasseh, Melissa Bollmann‐Jenkins, Ann Partridge, Virginia Kaklamani, Rowen Chlebowski, Sharon Larson & Marisa Weiss. (2022)
Risk factors for heightened
COVID‐19‐Related
anxiety among breast cancer patients
. Cancer Medicine 12:3, pages 3577-3588.
Crossref
Crossref
Fahimeh Safarnezhad Tameshkel, Shabnam Abedin Dargoush, Bahareh Amirkalali, Saeedeh Javadi, Ali Ghiaseddin, Yousef Alimohamadi, Ali Basi, Mahin Jamshidi Makiani, Farhad Zamani & Mohammad Hadi Karbalaie Niya. (2023) SARS-CoV-2 antibody response after BBIBP-CorV (Sinopharm) vaccination in cancer patients: A case-control study. Frontiers in Medicine 9.
Crossref
Crossref
Samaneh KeshavarzSomayeh KeshavarzNasrin ZiamajidiSajedeh Daei. (2023) Immune Response to COVID-19 Vaccination in Hematologic Malignancies: A Mini-Review. Chonnam Medical Journal 59:1, pages 24.
Crossref
Crossref
Noppacharn Uaprasert, Palada Pitakkitnukun, Nuanrat Tangcheewinsirikul, Thita Chiasakul & Ponlapat Rojnuckarin. (2022) Immunogenicity and risks associated with impaired immune responses following SARS-CoV-2 vaccination and booster in hematologic malignancy patients: an updated meta-analysis. Blood Cancer Journal 12:12.
Crossref
Crossref
S H Chong, L A Burn, T K M Cheng, I S Warr & J C Kenyon. (2022) A review of COVID vaccines: success against a moving target. British Medical Bulletin 144:1, pages 12-44.
Crossref
Crossref
Jingjing Lv, Hui Wu, Junjie Xu & Jiaye Liu. (2022) Immunogenicity and safety of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine: a systematic review. Infectious Diseases of Poverty 11:1.
Crossref
Crossref
Tahoora Mousavi, Monireh Golpour, Reza Alizadeh-Navaei & Alireza Mardomi. (2022) The immunogenicity of an inactivated vaccine against SARS-CoV-2 in healthy individuals: A systematic review and meta-analysis. Transplant Immunology 75, pages 101732.
Crossref
Crossref
Muna Almasri, Khalifa Bshesh, Wafa Khan, Malik Mushannen, Mohammad A. Salameh, Ameena Shafiq, Ahamed Lazim Vattoth, Nadine Elkassas & Dalia Zakaria. (2022) Cancer Patients and the COVID-19 Vaccines: Considerations and Challenges. Cancers 14:22, pages 5630.
Crossref
Crossref
Zahraa Haleem Al-qaim, Hasanain Kamil Hasan Owadh, Sarah A. Ali, Alaa S. Hussein, Thamer Ramadhan Ameen, Ayshan Kolemen, Ghassan A. Washi & Abduladheem Turki Jalil. (2022) COVID-19 vaccination in patients with cancer: Opportunities and challenges. Frontiers in Oncology 12.
Crossref
Crossref
Xiaoming Li, Xia Yang & Zong Ning. (2022) Efficacy and safety of COVID-19 inactivated vaccine: A meta-analysis. Frontiers in Medicine 9.
Crossref
Crossref
Sheng-Wei Cai, Jin-Yan Chen, Rong Wan, De-Jian Pan, Wei-Lin Yang & Ren-Gui Zhou. (2022) Efficacy and safety profile of two-dose SARS-CoV-2 vaccines in cancer patients: An observational study in China. World Journal of Clinical Cases 10:31, pages 11411-11418.
Crossref
Crossref
Rui Song, Li Liu, Qingbo Pan, Jin Liu, Jiahe Tan, Juan Deng, Qin Deng, Zijin Lin, Min Chen, Mingli Peng, Hong Ren & Jia Ming. (2022) Short-term safety and immunogenicity of inactivated and peptide-based SARS-CoV-2 vaccines in patients with endocrine-related cancer. Frontiers in Immunology 13.
Crossref
Crossref
Amirreza Manteghinejad, Saeedeh Arabzadeh, Zahra Rezaian, Mehran Sharifi & Shaghayegh Haghjooy Javanmard. (2022) COVID-19 Breakthrough Infections Among Patients with Cancer Receiving Sinopharm BBIBP-CorV Vaccine. International Journal of Cancer Management 15:10.
Crossref
Crossref
Haitam Lamtai, Saber Boutayeb, Hind Mrabti, Ibrahim El Ghissassi & Hassan Errihani. (2022) Cancer patients and COVID-19 vaccination, from safety to protocol adherence: A real-life setting report. Frontiers in Oncology 12.
Crossref
Crossref
Violeta Snegarova, Dimitrina Miteva, Milena Gulinac, Monika Peshevska-Sekulovska, Hristiana Batselova & Tsvetelina Velikova. (2022) COVID-19 in patients with gastrointestinal stromal tumors: Recommendations for management and vaccination. World Journal of Gastrointestinal Pathophysiology 13:5, pages 170-177.
Crossref
Crossref
Atike Pınar Erdoğan, Ferhat Ekinci, Sinem Akçalı & Gamze Göksel. (2022) Factors affecting the serologic response to SARS-CoV-2 vaccination in patients with solid tumors: A prospective study. Journal of Infection and Chemotherapy 28:9, pages 1310-1316.
Crossref
Crossref
Tong Li, Rui Song, Jingjie Wang, Jianbo Zhang, Hongxing Cai, Hongmei He, Wei Hu, Dajun Yu, Chuanhu Wang, Qingbo Pan, Mingli Peng, Hong Ren & Peng Zhu. (2022) Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in people with gastrointestinal cancer. International Journal of Infectious Diseases 122, pages 874-884.
Crossref
Crossref
Haoran Li, Kamal Kant Sahu, Shruti Adidam Kumar, Blake Nordblad, Nicolas Sayegh, Nishita Tripathi, Vinay Mathew Thomas, Sumati Gupta, Benjamin L. Maughan, Neeraj Agarwal & Umang Swami. (2022) A retrospective study to evaluate the efficacy and safety of SARS-CoV-2 vaccine in patients with advanced genitourinary cancers. Heliyon 8:9, pages e10583.
Crossref
Crossref
Mario Forrester, Luiza Breitenfeld, Miguel Castelo-Branco & Jorge Aperta. (2022) The Effects of the COVID-19 Pandemic in Oncology Patient Management. International Journal of Environmental Research and Public Health 19:15, pages 9041.
Crossref
Crossref
Petra Langerbeins & Michael Hallek. (2022) COVID-19 in patients with hematologic malignancy. Blood 140:3, pages 236-252.
Crossref
Crossref
Chao Wang, Lin-Yi Chen, Qing-Bin Lu & Fuqiang Cui. (2022) Vaccination with the Inactivated Vaccine (Sinopharm BBIBP-CorV) Ensures Protection against SARS-CoV-2 Related Disease. Vaccines 10:6, pages 920.
Crossref
Crossref
Annika Fendler, Elisabeth G. E. de Vries, Corine H. GeurtsvanKessel, John B. Haanen, Bernhard Wörmann, Samra Turajlic & Marie von Lilienfeld-Toal. (2022) COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety. Nature Reviews Clinical Oncology 19:6, pages 385-401.
Crossref
Crossref
Mahlagha Dehghan, Fatemeh Sadat Hoseini & Mohammad Ali Zakeri. (2022) Psychosomatic Symptoms in Terminally Ill Cancer Patients and Its Relation With Using Complementary and Alternative Medicines: A Cross-Sectional Study in Southeast Iran. Frontiers in Psychiatry 13.
Crossref
Crossref
Yuling Han, Jiaxin Yang, Danshuang He, Yang Feng, Xiaoman Liu, Yu Min, Shenghao Fan, Guobing Yin & Daixing Hu. (2022) Safety and Immunogenicity of Inactivated and Recombinant Protein SARS-CoV-2 Vaccines in Patients With Thyroid Cancer. Frontiers in Immunology 13.
Crossref
Crossref
Seyed Alireza Javadinia, Kimia Alizadeh, Mohammad-Shafi Mojadadi, Fateme Nikbakht, Farzaneh Dashti, Maryam Joudi, Hadi Harati, James S. Welsh, Seyed Amir Farahmand & Fahimeh Attarian. (2022) COVID-19 Vaccination in Patients With Malignancy; A Systematic Review and Meta-Analysis of the Efficacy and Safety. Frontiers in Endocrinology 13.
Crossref
Crossref
Maryam Joudi, Maryam Moradi Binabaj, Pejman Porouhan, Babak PeyroShabany, Mohsen Tabasi, Danial Fazilat-Panah, Mahtab Khajeh, Arezoo Mehrabian, Mansoureh Dehghani, James S. Welsh, Batol Keykhosravi, Azam Akbari Yazdi, Mona Ariamanesh, Ahmad Ghasemi, Gordon Ferns & Seyed Alireza Javadinia. (2022) A Cohort Study on the Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV) in Patients With Breast Cancer; Does Trastuzumab Interfere With the Outcome?. Frontiers in Endocrinology 13.
Crossref
Crossref
Suranjith L Seneviratne, Pamodh Yasawardene, Widuranga Wijerathne & Buddhika Somawardana. (2022) COVID-19 vaccination in cancer patients: a narrative review. Journal of International Medical Research 50:3, pages 030006052210861.
Crossref
Crossref
Zeinab Mohseni Afshar, Rezvan Hosseinzadeh, Mohammad Barary, Soheil Ebrahimpour, Amirmasoud Alijanpour, Babak Sayad, Dariush Hosseinzadeh, Seyed Rouhollah Miri, Terence T. Sio, Mark J. M. Sullman, Kristin Carson‐Chahhoud & Arefeh Babazadeh. (2021) Challenges posed by COVID‐19 in cancer patients: A narrative review. Cancer Medicine 11:4, pages 1119-1135.
Crossref
Crossref
Tamás Ferenci & Balázs Sarkadi. (2022) RBD-specific antibody responses after two doses of BBIBP-CorV (Sinopharm, Beijing CNBG) vaccine. BMC Infectious Diseases 22:1.
Crossref
Crossref
Olivera Marković, Anica Divac, Ilija Bukurecki, Marija Branković, Igor Jovanović, Predrag Đuran & Marija Zdravković. (2022) Clinical characteristics of COVID-19 and the efficacy of vaccination in patients with hematologic malignancies. Srpski medicinski casopis Lekarske komore 3:1, pages 75-86.
Crossref
Crossref
Ke Zhou, Jean-Luc Raoul, Audrey Blanc-Lapierre, Valérie Seegers, Michèle Boisdron-Celle, Marianne Bourdon, Hakim Mahammedi, Aurélien Lambert, Camille Moreau-Bachelard, Mario Campone, Thierry Conroy, Frédérique Penault-Llorca, Martine M Bellanger & Frédéric Bigot. (2022) COVID-19 Infections in Cancer Patients Were Frequently Asymptomatic: Description From a French Prospective Multicenter Cohort (PAPESCO-19). Clinical Medicine Insights: Oncology 16, pages 117955492210901.
Crossref
Crossref
Mozaffar Aznab, Narges Eskandari Roozbahani & Homa Moazen. (2022) Clinical Characteristics and Risk Factors of COVID-19 in 60 Adult Cancer Patients. Clinical Medicine Insights: Oncology 16, pages 117955492210741.
Crossref
Crossref
Yongliang Feng, Jing Chen, Tian Yao, Yue Chang, Xiaoqing Li, Rongqin Xing, Hong Li, Ruixue Xie, Xiaohong Zhang, Zhiyun Wei, Shengcai Mu, Ling Liu, Lizhong Feng & Suping Wang. (2021) Safety and immunogenicity of inactivated SARS-CoV-2 vaccine in high-risk occupational population: a randomized, parallel, controlled clinical trial. Infectious Diseases of Poverty 10:1.
Crossref
Crossref